We have located links that may give you full text access.
Spin crossover Fe(ii) complexes of a cross-bridged cyclam derivative.
A cross-bridged cyclam derivative containing two 2-pyridylmethyl pendant arms (L = 4,11-bis((pyridin-2-yl)methyl)-1,4,8,11-tetraaza-bicyclo[6.6.2]hexadecane) was synthesized by dialkylation of the cross-bridged cyclam with 2-chloromethylpyridine. A series of Fe(ii) complexes with L and different counter-anions of the formulas [Fe(L)][FeCl4]·H2O (1·H2O), [Fe(L)]Cl2·4H2O (2·4H2O), [Fe(L)](BF4)2·0.5CH3CN (3·0.5CH3CN) and [Fe(L)](BPh4)2·CH3OH (4·CH3OH) was prepared and thoroughly characterized. In all the cases, the [Fe(L)]2+ cation adopts a cis-V configuration with a distorted octahedral geometry, and with the FeN6 donor set. The magnetic measurements within the temperature interval of 5-400 K revealed the spin crossover (SCO) behaviour of all the complexes with the transition temperature T1/2 increasing with the counter anion in the order BF4- (3) < [FeCl4]2- (1) < BPh4- (4). However, the SCO process was complete in the case of compound 3 only, with T1/2 = 177 K, which proceeded after removal of co-crystallized CH3CN molecules accompanied by a change of the crystallographic phase. The SCO behaviour of 3 was also confirmed by a single crystal X-ray analysis providing the average Fe-N distances of 2.086 Å at 120 K and 2.197 Å at 293 K typical of low-spin, and high-spin FeII complexes, respectively. The obtained results clearly showed that the nature of the counter anion and the presence/absence of co-crystallized solvent molecule(s) significantly affected the temperature as well as the abruptness of the spin transition. This is the first report of SCO behaviour observed for iron complexes containing a cross-bridged cyclam derivative.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app